Patents by Inventor Didier Landais

Didier Landais has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Albumin derivatives with therapeutic functions
    Publication number: 20050048471
    Abstract: Utilization of albumin as a stable plasma transporter with a therapeutic function that is derived from a membrane receptor. The present invention is exemplified by the description of new therapeutic agents that can be used in the treatment of Acquired Immunodeficiency Syndrome: hybrid macromolecules composed of albumin derivatives coupled to derivatives of the CD4 receptor having a normal or a higher affinity for the HIV-1 virus.
    Type: Application
    Filed: March 8, 2004
    Publication date: March 3, 2005
    Applicant: Rhone-Poulenc Sante
    Inventors: Jerome Becquart, Reinhard Fleer, Philippe Hirel, David Klatzmann, Didier Landais, Jean-Francois Mayaux, Patrice Yeh
  • Albumin derivatives with therapeutic functions
    Publication number: 20030054554
    Abstract: Utilization of albumin as a stable plasma transporter with a therapeutic function that is derived from a membrane receptor. The present invention is exemplified by the description of new therapeutic agents that can be used in the treatment of Acquired Immunodeficiency Syndrome: hybrid macromolecules composed of albumin derivatives coupled to derivatives of the CD4 receptor having a normal or a higher affinity for the HIV-1 virus.
    Type: Application
    Filed: February 12, 2002
    Publication date: March 20, 2003
    Applicant: Rhone-Poulenc Sante
    Inventors: Jerome Becquart, Reinhard Fleer, Philippe Hirel, David Klatzmann, Didier Landais, Jean-Francois Mayaux, Patrice Yeh
  • Albumin derivatives with therapeutic functions
    Patent number: 6165470
    Abstract: Utilization of albumin as a stable plasma transporter with a therapeutic function that is derived from a membrane receptor. The present invention is exemplified by the description of new therapeutic agents that can be used in the treatment of Acquired Immunodeficiency Syndrome: hybrid macromolecules composed of albumin derivatives coupled to derivatives of the CD4 receptor having a normal or a higher affinity for the HIV-1 virus.
    Type: Grant
    Filed: January 8, 1998
    Date of Patent: December 26, 2000
    Assignee: Rhone-Poulenc
    Inventors: Jerome Becquart, Reinhard Fleer, Philippe Hirel, David Klatzmann, Didier Landais, Jean-Fran.cedilla.ois Mayaux, Patrice Yeh